Overfeeding Effects on Obesity
(EAT 2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how fat tissues expand during weight gain and how this affects heart and overall metabolic health. Participants will either maintain their weight (Control) or consume 30% more calories than their usual diet (Overfeeding) to observe bodily adjustments. The study could offer new insights into how weight gain impacts health, particularly conditions like type 2 diabetes. Men and pre-menopausal women with stable weight who are willing to follow study procedures might be suitable candidates. As an unphased study, this trial provides a unique opportunity to contribute to groundbreaking research on weight gain and metabolic health.
Will I have to stop taking my current medications?
The trial requires that you do not use certain medications that can affect weight, such as steroids, beta-blockers, and antipsychotics. If you are on these medications, you may need to stop them to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that consuming more calories than needed can lead to weight gain and increase the risk of health problems like type 2 diabetes and heart disease. Studies indicate that excessive calorie intake is a key factor in weight gain and can cause issues related to obesity. One study found that consuming too many calories, especially from highly processed foods, can lead to weight gain.
While overeating isn't usually a safety concern by itself, the long-term effects, such as potential heart problems, are important to consider. This study aims to understand how short-term weight gain affects fat tissue and overall health. Although participants in this trial temporarily consume more calories, the process is carefully monitored to ensure safety.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the effects of overfeeding on obesity, a novel approach compared to typical treatments like dietary changes, exercise, and medication. Unlike standard methods that focus on weight loss, this trial investigates how controlled overfeeding impacts the body's energy balance and weight regulation. By understanding the body's response to increased caloric intake, researchers hope to uncover new insights into obesity management and potentially develop innovative strategies to address weight gain and its associated health risks.
What evidence suggests that this trial's treatments could be effective for obesity?
This trial will compare the effects of overfeeding with a control group. Research has shown that consuming more calories than the body needs, known as overfeeding, can lead to weight gain. One study found that overfeeding caused an average weight gain of 2.2 kg, with about half of that being fat. Another study demonstrated that eating excessively for two weeks resulted in noticeable weight gain and reduced hunger afterward. However, some individuals gain weight more easily than others when they overeat. While the amount of weight and fat gained can vary, the general trend is an increase in body size. Understanding how fat tissue grows during overeating can help predict future health issues like metabolic syndrome or type 2 diabetes.36789
Who Is on the Research Team?
Ursula White, Ph.D.
Principal Investigator
Pennington Biomedical Research Center
Are You a Good Fit for This Trial?
This trial is for men and pre-menopausal women aged 18-42 with a BMI of 25-30, willing to follow study procedures, maintain physical activity levels, drink labeled water for research, and use contraception if necessary. Excluded are those pregnant or planning pregnancy soon, with diabetes or high fasting blood glucose, high blood pressure, eating disorders, certain medication usage including weight loss drugs or antidepressants less than 3 months old.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo overfeeding with a 30% increase in caloric intake to study adipose tissue expansion and remodeling
Follow-up
Participants are monitored for changes in adipose tissue and cardiometabolic health outcomes after the treatment phase
What Are the Treatments Tested in This Trial?
Interventions
- Control
- Overfeeding
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pennington Biomedical Research Center
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator